Complete financial analysis of Universe Pharmaceuticals INC (UPC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Universe Pharmaceuticals INC, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Aurora Solar Technologies Inc. (ACU.V) Income Statement Analysis – Financial Results
- Nintendo Co., Ltd. (NTDOY) Income Statement Analysis – Financial Results
- Vietnam Enterprise Investments Limited (VEIL.L) Income Statement Analysis – Financial Results
- Ichigo Inc. (ICHIF) Income Statement Analysis – Financial Results
- Aims Property Securities Fund (APW.AX) Income Statement Analysis – Financial Results
Universe Pharmaceuticals INC (UPC)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.universe-pharmacy.com
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 32.31M | 40.14M | 47.98M | 30.70M | 33.23M | 28.51M |
| Cost of Revenue | 21.99M | 18.25M | 22.66M | 16.61M | 19.82M | 15.11M |
| Gross Profit | 10.32M | 21.89M | 25.33M | 14.09M | 13.41M | 13.41M |
| Gross Profit Ratio | 31.93% | 54.53% | 52.78% | 45.90% | 40.35% | 47.03% |
| Research & Development | 4.86M | 7.64M | 5.47M | 583.13K | 618.44K | 789.38K |
| General & Administrative | 2.22M | 1.75M | 3.30M | 1.24M | 713.65K | 704.87K |
| Selling & Marketing | 6.78M | 19.08M | 2.97M | 1.56M | 1.58M | 1.68M |
| SG&A | 9.00M | 20.84M | 6.27M | 2.80M | 2.29M | 2.39M |
| Other Expenses | -17.53K | 430.31K | -80.43K | 365.77K | 445.77K | 5.01K |
| Operating Expenses | 13.84M | 28.91M | 11.74M | 3.74M | 3.36M | 3.65M |
| Cost & Expenses | 35.84M | 47.16M | 34.39M | 20.35M | 23.18M | 18.75M |
| Interest Income | 0.00 | 0.00 | 239.55K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 156.79K | 162.40K | 101.60K | 123.76K | 129.27K | 164.92K |
| Depreciation & Amortization | 508.79K | 533.95K | 446.88K | 410.08K | 418.43K | 452.73K |
| EBITDA | -3.22M | -7.33M | 14.20M | 10.61M | 10.17M | 10.11M |
| EBITDA Ratio | -9.95% | -15.94% | 29.15% | 34.95% | 31.59% | 35.91% |
| Operating Income | -3.53M | -7.02M | 13.59M | 10.25M | 9.75M | 9.66M |
| Operating Income Ratio | -10.92% | -17.49% | 28.32% | 33.39% | 29.35% | 33.87% |
| Total Other Income/Expenses | -322.80K | -545.35K | 88.34K | -151.29K | -99.77K | -138.28K |
| Income Before Tax | -3.85M | -7.98M | 13.68M | 10.10M | 9.65M | 9.52M |
| Income Before Tax Ratio | -11.91% | -19.89% | 28.51% | 32.90% | 29.05% | 33.38% |
| Income Tax Expense | 2.31M | 752.42K | 2.36M | 2.54M | 2.10M | 1.92M |
| Net Income | -6.16M | -8.74M | 11.32M | 7.56M | 7.55M | 7.60M |
| Net Income Ratio | -19.08% | -21.76% | 23.59% | 24.62% | 22.73% | 26.66% |
| EPS | -1.70 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
| EPS Diluted | -1.70 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
| Weighted Avg Shares Out | 3.63M | 3.63M | 3.63M | 3.68M | 3.68M | 21.00M |
| Weighted Avg Shares Out (Dil) | 3.63M | 3.63M | 3.63M | 3.68M | 3.68M | 21.00M |
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Ji'an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market...
“I Will Make UPC Great Again!”—UPC Presidential Hopeful Othieno Vows as He Praises Obote’s Legacy
Appearing on the NBS political program ‘People and Power’ yesterday, Joseph Othieno, a candidate for the Uganda People’s Congress (UPC) presidency, painted a picture of the party’s historical journey and his role in shaping its direction as He praised the...
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
JI'AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal...
UPC Tasks President Museveni to Produce Evidence of Vote Rigging in Courts of Law
Uganda People’s Congress (UPC) has tasked President Yoweri Museveni to produce evidence of the 2021 Presidential elections, in which the President recently said his votes were rigged by 1 million votes by the National Unity Platform (NUP). UPC Spokesperson, Sharon...
UPC Concerned over Welfare of Medical Interns
Uganda People’s Congress (UPC) has raised concerns on the wellbeing of Medical Interns. The UPC concerns were voiced in a statement released on Wednesday, during a Press Conference at the UPC Head Office located on Uganda House in Kampala. “President...
UPC Calls on Government to Impact Skills Development Education in Youth
Uganda People’s Congress (UPC) has called on the Government to put into place the necessary education and skills development in youth to enable them to grow up as reproductive and responsible citizens. The call was made at a press conference,...
UPC Raises Red Flag on Road Carnage, City Robberies
Uganda People’s Congress (UPC) on Wednesday raised concerns about the Traffic Police Report that revealed that over 80 people died in road accidents in just a period of one week from 7th – 13th July, 2024. “The Party extends heartfelt...
UPC Condemns Re- Arrest of Legislator Released on Bail for Corruption Charges
The Uganda People’s Congress (UPC) has condemned with strongest terms the immediate re-arrest of Hon. Akamba Paul (Busiki County) by security operatives, immediately the legislature was granted bail by the competent Court of Law on charges of corruption. The condemnation...
UPC Calls on Government to Address Workers’ Rights on International Labour Day
Uganda People’s Congress (UPC) has called on the Government to address workers’ rights during the International Labour Day celebrations, slated for 1st May 2024, at Mukabura Grounds in Fort Portal City. Ms. Arach Oyat Sharon, the UPC Spokesperson, while addressing...
Place Interest of the Common Man at the Centre – Jimmy Akena
Uganda People’s Congress (UPC) President, Hon. Jimmy Akena has called upon the Government to place the interest of the common man at the centre, while addressing the ongoing standoff between traders and Uganda Revenue Authority over taxes. Hon. Akena, while...
Source: https://incomestatements.info
Category: Stock Reports